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ABSTRACT 17 
Carbapenem-resistant Enterobacteriaceae (CRE) have spread worldwide, leaving 18 
very few treatment options available. New Delhi metallo-beta-lactamase (NDM) is the 19 
main carbapenemase mediating CRE resistance, and is of increasing concern. 20 
NDM-positive Enterobacteriaceae of human origin are frequently identified; however, 21 
the emergence of NDM, particularly novel variants, in bacteria of food animal origin has 22 
never been reported. Here, we characterize a novel NDM variant (assigned NDM-17) 23 
identified in a β-lactam-resistant sequence type 48 (ST48) Escherichia coli strain that 24 
was isolated from a chicken in China. Compared to NDM-1, NDM-17 had three amino 25 
acid substitutions (V88L, M154L, E170K) that confer significantly enhanced 26 
carbapenemase activity, When compared to NDM-5, NDM-17 had only one amino acid 27 
substitution (E170K) and slightly increased isolate resistance toward carbapenem, as 28 
indicated by increased MIC values. The gene encoding NDM-17 (blaNDM-17) was located 29 
on an IncX3 plasmid, which was readily transferrable to recipient E. coli J53 by 30 
conjugation, suggesting the possibility of rapid dissemination of blaNDM-17. Enzyme 31 
kinetics showed that NDM-17 could hydrolyze all β-lactams tested, except for aztreonam, 32 
and had significantly higher affinity for all β-lactams tested compared to NDM-5. The 33 
emergence of this novel NDM variant could pose a threat to public health because of its 34 
transferability and enhanced carbapenemase activity.  35 
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INTRODUCTION 36 
Carbapenem-resistant Enterobacteriaceae (CRE) have been recognized as an urgent 37 
antibiotic resistance threat by the Centers for Disease Control in the US, and have 38 
become a global problem in recent years (1). The resistance exhibited by CRE is largely 39 
mediated by the production of carbapenemases (2), especially metallo-β-lactamases 40 
(MBLs) such as VIM, IMP, and New Delhi metallo-β-lactamase (NDM), which can 41 
hydrolyze almost all carbapenem β-lactams (3). Since its discovery in India in 2008, 42 
NDM has been identified throughout the world, and its identification in China has 43 
become common (4, 5). Currently, there are 16 NDM variants (www.lahey.org/studies), 44 
with amino acid substitutions at 14 positions. The evolution and spread of NDM are 45 
rapid, and NDM-positive bacteria are found in the wider community environment, not 46 
just hospitals (6). The spread of NDM-positive bacteria depends on fecal-oral 47 
transmission, and an important route for this transmission is animal-derived food (6). The 48 
importance of minimizing the carriage of NDM-positive bacteria by food animals for 49 
public health was underlined by the discovery of non-human sources of NDM (7,8). In 50 
comparison with the high prevalence of NDM-positive Enterobacteriaceae of human 51 
origin, there are few reports on CRE from food animals. Furthermore, none of the novel 52 
NDM variants described to date were originally identified in bacteria isolated from food 53 
animals. Here we describe the characterization of a novel NDM variant in Escherichia 54 
coli isolated from a chicken. 55 
 o
n
 July 10, 2017 by Cardiff Univ
http://aac.asm
.org/
D
ow
nloaded from
 
4 
 
MATERIALS AND METHODS 56 
Identiﬁcation and phenotypic characterization of the isolate. 57 
A route annual surveillance of CRE of animal origin was performed to monitor its 58 
dissemination. E. coli AD-19R was isolated from a cloacal swab taken from a chicken at 59 
a commercial poultry farm in Shandong Province, China, in 2015. The sample was plated 60 
directly onto CHROMagar KPC selective medium (CHROMagar, Paris, France), which 61 
selects for the growth of carbapenem-resistant Enterobacteriaceae (9). The bacterial 62 
species was identiﬁed by matrix-assisted laser desorption/ionization-time of flight mass 63 
spectrometry (Bruker Daltonik, Bremen, Germany), and conﬁrmed by 16S rRNA 64 
sequencing (10). The modiﬁed Hodge test, using imipenem and meropenem discs, was 65 
conducted to confirm the phenotype of carbapenemase production. 66 
Antimicrobial susceptibility testing. 67 
The MICs of the original isolate (AD-19R), its transconjugants and transformants, 68 
and two reference isolates (E. coli strain YW carrying blaNDM-1 and DZ2-29R carrying 69 
blaNDM-5) to several antimicrobials (listed in Table 1) were determined using a broth 70 
microdilution method as recommended by the Clinical and Laboratory Standards 71 
Institute (11). The E. coli ATCC 25922 was used as a quality control strain. 72 
Detection of β-lactamase genes and whole-genome sequencing. 73 
Whole-cell DNA was extracted from isolates AD-19R using a QiaAmp Mini kit 74 
according to the manufacturer’s recommendations (Qiagen, Hilden, Germany). PCR and 75 
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DNA sequencing were conducted to screen for known β-lactamase genes (MBL genes 76 
blaDIM, blaGIM, blaIMP, blaNDM, blaSIM, blaSPM, and blaVIM) as described previously (12). A 77 
150-bp paired-end library was constructed following the standard Illumina (San Diego, 78 
CA, USA) paired-end protocol, and the whole genome of E. coli AD-19R, including 79 
plasmid pAD-19R extracted from transformants, was sequenced on the Illumina HiSeq 80 
2500 system. Results were analyzed using CLC Genomics Workbench version 9.0 (CLC 81 
bio, Aarhus, Denmark), and each predicted ORF was used as a query against the 82 
GenBank database of the National Center for Biotechnology Information using a BLAST 83 
search. Gaps in the sequence were closed by PCR and Sanger sequencing (13). 84 
MLST, Southern blotting, transconjugation, and plasmid analysis. 85 
MLST was performed as described previously to identify the sequence type of 86 
isolate AD-19R (14). Southern blot analysis was used with specific blaNDM 87 
digoxigenin-labeled probes to locate blaNDM genes. Transconjugation assays were used to 88 
evaluate the horizontal transferability of blaNDM, with E. coli J53 as the recipient, and 89 
isolate AD-19R as the donor. The transconjugants were selected on MacConkey agar 90 
containing 100 mg/l sodium azide and 1 mg/l meropenem and the transfer frequency was 91 
calculated by transconjugants/donors. PCR with specific primers was used to confirm the 92 
presumptive transconjugants (15). Plasmid incompatibility groups were determined by 93 
two PCR-based replicon typing methods (16,17). 94 
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Cloning of blaNDM-17, blaNDM-5 and blaNDM-1. 95 
To compare the beta-lactamase activities of both NDM-1 and NDM-5 with NDM-17, 96 
the respective genes (blaNDM-1, blaNDM-5 and blaNDM-17) with their native promoters were 97 
amplified by PCR using primers NP-NDM-F 98 
(5′-CGGGATCCCACCTCATGTTTGAATTCGC-3ʹ) and NP-NDM-R 99 
(5′-CCCAAGCTTCTCTGTCACATCGAAATCGC-3ʹ), and cloned into the pHSG398 100 
vector (Takara Bio, Dalian, China). The resulting plasmids were named 101 
pHSG398/NP-NDM-1, pHSG398/NP-NDM-5 and pHSG398/NP-NDM-17, respectively. 102 
The complete blaNDM-1 blaNDM-5 and blaNDM-17 ORFs were obtained by PCR using 103 
primers NDM-F (5′-CGGGATCCATGGAATTGCCCAATATTATG-3′) and NDM-R 104 
(5′-CCCAAGCTTTCAGCGCAGCTTGTCGGCCAT-3′), cloned into pHSG398, and 105 
named pHSG398/NDM-1, pHSG398/NDM-5 and pHSG398/NDM-17, respectively. 106 
Subsequently, pHSG398/NP-NDM-1, pHSG398/NP-NDM-5, pHSG398/NP-NDM-17, 107 
pHSG398/NDM-1, pHSG398/NDM-5 and pHSG398/NDM-17 were transformed into E. 108 
coli DH5α by electrotransformation, and confirmed by PCR and DNA sequencing 109 
(18,19). 110 
Expression and purification of NDM-17 and NDM-5. 111 
The ORFs coding for NDM-5 and NDM-17 without signal peptide regions were 112 
amplified using primers BamHI-TEV-NDM-F 113 
(5ʹ-ATGGATCCGAAAACCTGTATTTCCAAGGCCAGCAAATGGAAACTGGCGAC-114 
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3′) and XhoI-NDM-R (5′ATCTCGAGTCAGCGCAGCTTGTCGGCCATG-3′) and then 115 
cloned into the pET28a expression vector (Merck Millipore, Danvers, MA, USA). The 116 
resulting plasmid was transformed into E. coli BL21 (DE3) as per the manufacturer’s 117 
instructions (TransGen Biotech, Beijing, China). Ni-nitrilotriacetic acid (NTA) agarose 118 
was used to purify the recombinant NDM proteins according to the manufacturer’s 119 
instructions (Qiagen, Hilden, Germany). His tags were removed by cleaving with Turbo 120 
TEV protease (Accelagen, San Diego, CA, USA), and untagged proteins were puriﬁed by 121 
an additional passage in Ni-NTA agarose. The purity of the recombinant NDM proteins 122 
was estimated by SDS-PAGE, and protein concentration was measured using a Pierce 123 
bicinchoninic acid protein assay kit (Thermo Scientiﬁc, Waltham, MA, USA). 124 
β-lactamase activity was monitored with nitroceﬁn (Oxoid Ltd., Basingstoke, United 125 
Kingdom) during the puriﬁcation procedure, as per the manufacturer’s instructions.  126 
Determination of kinetic parameters. 127 
A kinetic study was conducted to measure β-lactamase activity and compare the 128 
catalytic properties of NDM-17 and NDM-5. Initial hydrolysis rates were determined in 129 
50 mM phosphate buffer (pH 7.0) containing 30 µM Zn2+ at 25°C (20), using a 130 
SpectraMax M5 multi-detection microplate reader (Molecular Devices, Sunnyvale, CA, 131 
USA). The Km and kcat values and the kcat/Km ratio were determined from three individual 132 
experiments using wavelengths and extinction coefﬁcients as previously described 133 
(21,22), and by constructing a Lineweaver-Burk plot. 134 
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Accession number(s). The sequence of novel NDM variant gene has been deposited 135 
in GenBank under accession no. KX812714, and assigned to be blaNDM-17 and its 136 
BioSample has also been submitted to NCBI. The complete nucleotide sequence of 137 
plasmid pAD-19R has been deposited as GenBank accession no. KX833071. 138 
RESULTS AND DISCUSSION 139 
Characterization of E. coli AD19R. 140 
The E. coli AD-19R isolate was resistant to all β-lactams tested, including 141 
imipenem, meropenem, ertapenem, and aztreonam, but was sensitive to tigecycline and 142 
colistin (Table 1). A positive result in the modified Hodge test demonstrated the 143 
carbapenemase production phenotype. The presence of blaNDM in AD19R was confirmed 144 
by PCR and sequencing. Analysis of the draft genome of AD19R by whole-genome 145 
sequencing revealed a novel blaNDM variant, assigned blaNDM-17 (GenBank accession no. 146 
KX812714), as well as the presence of additional β-lactamase genesblaCTX-M-64 and 147 
blaTEM-1B, sulfonamides resistance gene sul2 and aminoglycoside resistance genes 148 
aph(3')-Ia, aadA5, rmtB. In comparison with blaNDM-1, blaNDM-17 contained point 149 
mutations at nucleotide positions 262 (G→T), 460 (A→C), and 508 (G→A). These 150 
substitutions corresponded to amino acid variants V88L, M154L, and E170K, 151 
respectively, with the E170K being a novel substitution. Multi-locus sequence typing 152 
(MLST) analysis showed that AD19R belonged to sequence type 48 (ST48), which is 153 
most commonly associated with blaCTX-M-harboring E. coli isolates in humans (23). 154 
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These findings suggest the possibility of transfer of E. coli isolates harboring blaNDM 155 
from humans to food animals (8, 24). 156 
Transferability and localization of blaNDM-17 and plasmid analysis. 157 
Transconjugation assays showed that blaNDM-17 was successfully transferred to E. 158 
coli J53, with a transfer frequency of ~6.32×10−9 per donor. S1-pulsed-field gel 159 
electrophoresis and Southern blotting revealed that a plasmid band from the 160 
transconjugants (designated AD19/J53), with a size of ~47 kb, hybridized with the 161 
blaNDM probe (Fig. 1). AD19/J53 exhibited a similar resistance profile to parental isolate 162 
AD19R, except for aztreonam. 163 
The complete DNA sequence of pAD-19R (carrying blaNDM-17), isolated from 164 
AD19/J53 transconjugants, was obtained by whole-genome sequencing, with an average 165 
depth of coverage of 510. It was a circular, 46,161-bp plasmid with a G+C content of 166 
46.6% and 60 putative open reading frames (ORFs) (Fig. 2). pAD-19R was identified as 167 
an IncX3 plasmid, with a typical backbone structure for this plasmid type, including 168 
regions involved replication, partitioning, plasmid maintenance, transcriptional activation, 169 
and conjugation/type IV secretion (25,26). Although IncX3 plasmids are considered low 170 
prevalence, narrow-host-range plasmids of Enterobacteriaceae (27), they may have 171 
served as a common vehicle mediating blaNDM dissemination in China, and might be 172 
responsible for the rapid spread of NDM-carrying isolates (4,28), a theory supported by 173 
our study. 174 
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BLAST homology analysis showed that pAD-19R had 99% (46142/46161 bp) 175 
identity and 100% query coverage with pNDM5_IncX3 (GenBank accession no. 176 
KU761328), a 46,161 bp IncX3 plasmid isolated from Klebsiella pneumoniae (SZ204), 177 
recently reported in China (29). Notably, strain SZ204 carried a mcr-1-harboring plasmid, 178 
in addition to pNDM5_IncX3, which makes co-dissemination of IncX3 179 
blaNDM-5-harboring plasmids and mcr-1-harboring plasmids. In addition, the pAD-19R 180 
sequence was similar to other five IncX3 blaNDM-allele-harboring plasmids: plasmid 181 
unnamed2 from K. pneumoniae strain NUHL24835 (GenBank accession no. CP014006) 182 
isolated in China, pNDM_MGR194 (GenBank accession no. KF220657) from K. 183 
pneumoniae isolated in India (26), pEc1929 (GenBank accession no. KT824791) from E. 184 
coli isolated in China (30), pJEG027 (GenBank accession no. KF220657) from K. 185 
pneumoniae isolated in Australia (31), and pKpN01-NDM7 (GenBank accession no. 186 
CP012990) from K. pneumoniae isolated in Canada (32). Interestingly, all six plasmids, 187 
including pNDM5_IncX3, were carried by bacteria isolated from humans, whereas the E. 188 
coli strain carrying pAD-19R in our study was isolated from a chicken. This result 189 
further indicates the possible transfer of IncX3 blaNDM-17-harboring plasmids/isolates 190 
between humans and food-producing animals. Therefore, Enterobacteriaceae species 191 
carrying IncX3 blaNDM-17-harboring plasmids should be monitored worldwide. 192 
Further analysis of the pAD-19R sequence showed that it didn’t harbor other 193 
resistance genes apart from blaNDM-17 and ble. The sequence surrounding blaNDM-17 shares 194 
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a common genetic background with a 10,410-bp fragment, 195 
Tn3-IS3000-ΔISAba125-IS5-blaNDM-17-bleMBL-trpF-dsbC-IS26-ΔumnD (Region A in Fig. 196 
S1), which plays a crucial role in horizontal transmission, and may assist in horizontal 197 
transfer of blaNDM-17 among Enterobacteriaceae (33). Overall, these results warn that both 198 
the genetic environment of blaNDM-17 and the IncX3 blaNDM-17-harboring plasmids 199 
contribute to blaNDM-17 transmission among food-producing animals. The blaNDM-17 200 
carrying isolates would pose a threat to human health once the E. coli AD-19R 201 
transferred to humans through the food chain, and vice versa. 202 
Functional analysis of NDM-17 and characterization of kinetic parameters. 203 
NDM-17 had three amino acid substitutions (V88L, M154L, E170K) compared 204 
with NDM-1, but only one difference (E170K) in comparison with NDM-5, with which 205 
NDM-17 shares the closest relationship among the 16 reported NDM variants 206 
(www.lahey.org/studies). In order to determine the effects of these amino acid 207 
substitutions in NDM-17, especially E170K, cloning experiments and kinetic studies 208 
were performed by reference to NDM-5. 209 
All of the transformants were successfully cloned and confirmed by PCR. Strains 210 
containing pHSG398/NP-NDM-1, pHSG398/NP-NDM-5 and pHSG398/NP-NDM-17, 211 
with their native promoters identified no differences for all transformants by PCR and 212 
sequencing with M13 primers, exhibited resistance to all β-lactams tested, including 213 
meropenem and imipenem (Table 1). Interestingly, the constructs pHSG398/NDM-1, 214 
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pHSG398/NDM-5 and pHSG398/NDM-17, carrying complete ORFs without the native 215 
promoters, showed reduced susceptibility to penicillins and cephems, but were 216 
susceptible to carbapenem. This result confirmed that the wild-type promoter was crucial 217 
for carbapenem resistance (19). In addition, all transformants were susceptible to 218 
aztreonam, colistin, and tigecycline, which was consistent with previous reports (18,19). 219 
The profiles of β-lactams tested resistance for NDM-17 transformants were similar to 220 
those for corresponding NDM-5 transformants, however, the MICs of ertapenem and 221 
meropenem for pHSG398/NP-NDM-17 were slightly higher (2-fold) than those for 222 
pHSG398/NP-NDM-5 (Table 1). Importantly, the MICs of cefepime, ertapenem, and 223 
imipenem for DH5α (pHSG398/NP-NDM-17) were 2-fold higher than those of DH5α 224 
(pHSG398/NP-NDM-1). Furthermore, DH5α (pHSG398/NP-NDM-17) showed a 4-fold 225 
elevation in MIC for meropenem compared with DH5α (pHSG398/NP-NDM-1). These 226 
findings suggest that mutations outside the promoter region are responsible for the 227 
increased carbapenem resistance. 228 
Expression and purification experiments showed that the NDM-17 and NDM-5 229 
recombinant proteins were expressed at up to 90% purity, as evaluated by SDS-PAGE. 230 
Both NDM proteins were used to determine kinetic parameters, which revealed that 231 
NDM-17 and NDM-5 could hydrolyze all β-lactams tested, except for aztreonam (Table 232 
2). NDM-17 had similar kcat/Km ratios for almost β-lactams tested to NDM-5, except for 233 
significantly higher kcat/Km ratios for cefoxitin and penicillin G, and lower for ampicillin. 234 
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These results indicate that NDM-17 has similar enzymatic activity to NDM-5, which had 235 
been reported to increase the carbapenemase activity compared with NDM-1. Notably, 236 
the Km of NDM-17 for all β-lactams tested was obviously lower than that of NDM-5, 237 
especially for ceftazidime, penicillin G, ertapenem, imipenem, and meropenem (Table 2). 238 
These results suggest that NDM-17 has significantly higher affinity for all β-lactams 239 
tested than NDM-5. 240 
It is possible that the increased resistance and the higher enzyme activity of 241 
NDM-17 is conferred by the three amino acid substitutions (V88L, M154L, and E170K). 242 
The M154L substitution increases the carbapenemase activity of NDM-4 (M154L) (15), 243 
NDM-5 (V88L, M154L) (34-36), and NDM-7 (D130N, M154L) (19,37), indicating it 244 
may be responsible for the higher hydrolytic activity of NDM-17. NDM-4 and NDM-5 245 
are identical except for the V88L substitution in NDM-5, and NDM-5 has lower kcat/Km 246 
values for imipenem and meropenem than NDM-4 (38). This suggests that V88L might 247 
contribute to the decreased hydrolytic activity of NDM-5 towards carbapenems. 248 
NDM-17 shares the V88L and M154L substitutions with NDM-5, in addition to E170K. 249 
Our kinetic data showed that NDM-17 had significantly higher affinity for all β-lactams 250 
tested, and obviously increased catalytic efficiencies for cefoxitin and penicillin G. Thus, 251 
the E170K substitution should be responsible for the higher affinity and increased 252 
catalytic efficiencies of NDM-17. Interestingly, the D130G substitution increases 253 
carbapenemase activity, but NDM-8which contains both D130G and M154L, does not 254 
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exhibit increased hydrolytic activity for carbapenems (39). Thus, it is possible that 255 
certain amino acid substitutions may have different effects in different NDM variants, 256 
and the increased hydrolytic activity of NDM-17 was not the result of the cumulative 257 
effect of the individual V88L, M154L, and E170K amino acid substitutions, but rather 258 
the overall interaction of the three substitutions. 259 
To determine the locations of the three amino acid substitutions and analyze their 260 
effects on structure, a 3D model of NDM-17 was generated by homology modeling using 261 
NDM-1 as a template (PDB accession: 4EXS). The previously reported crystal structure 262 
of NDM-1 shows that the active site is formed by loops 3 and 10, at the bottom of a 263 
shallow groove, and amino acid triads that bind to zinc ions are formed by H120, H122, 264 
and H189, and D124, C208, and H250 (40,41). Currently, 16 amino acid substitutions 265 
have been reported in NDMs at 14 distinct amino acids: 28, 32, 36, 69, 74, 88, 95, 130, 266 
152, 154, 200, 222, 233, and 264. E170K represents a new amino acid substitution and 267 
site, which was far from the active site and exposed to the solvent. Although positions 88, 268 
154, and 170 are not located in the active site involved in binding to zinc ions (Fig. 3), 269 
they might still indirectly affect the formation of the active site, as was previously 270 
described (18). 271 
Conclusions. 272 
In this study, a novel NDM variant, NDM-17, was identified in a ST48 E. coli strain 273 
isolated from a chicken. This is the first report of a new NDM variant being isolated from 274 
 o
n
 July 10, 2017 by Cardiff Univ
http://aac.asm
.org/
D
ow
nloaded from
 
15 
 
a food animal. NDM-17 displayed higher affinity than NDM-5 against almost all 275 
β-lactams, as well as carbapenem confirmed by kinetic parameters, and increased 276 
carbapenemase activity compared to NDM-1 indicated by MICs. In addition, blaNDM-17 277 
was located on an IncX3 plasmid and was surrounded by multiple insertion sequences, 278 
mediating the rapid dissemination of blaNDM. Transmission of strains carrying blaNDM-17 279 
to humans via the food chain represents a serious threat to human health, and should be 280 
given further attention to ensure NDM-17-producing pathogens are efficiently monitored. 281 
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FIGURE LEGENDS 432 
FIG 1. Location of blaNDM-17 on E. coli plasmid AD-19R, separated by PFGE. Lane A, 433 
hybridization of the plasmid with a probe specific for blaNDM-17; lane B, plasmid from 434 
transconjugants AD19/J53; lane C, reference standard strain H9812 restricted by XbaI. 435 
 436 
FIG 2. Homology model of NDM-17. (A) Protein backbone of NDM, shown as a 437 
cartoon with the helices and strands. Amino acids binding to zinc ions (H120, H122, 438 
H189; D124, C208, H250) and three amino acid substitutions (L88, L154, and K170) are 439 
labeled and colored blue and red, respectively. (B) The three amino acid substitutions 440 
(red) were not located at the active sites (loop 3 (green) or loop 10 (green)), or near the 441 
amino acids binding to zinc ions (blue). 442 
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TABLE 1 β-lactam MICs for the NDM17-carrying original E. coli isolate, and its transconjugants and transformants 443 
Antibiotic 
 
AD19 
(NDM-17) AD19/J53 J53 
DH5α 
(pHSG398) 
DH5α 
(pHSG398/ 
NDM-1) 
DH5α 
(pHSG398/ 
NDM-5) 
DH5α 
(pHSG398/ 
NDM-17) 
DH5α 
(pHSG398/ 
NP-NDM-1) 
DH5α 
(pHSG398/ 
NP-NDM-5)
DH5α 
(pHSG398/ 
NP-NDM-17) 
Ampicillin >256 >256 4 2 >256 >256 >256 >256 >256 >256 
Aztreonam 256 0.063 0.063 0.032 0.063 0.032 0.063 0.063 0.032 0.063 
Amikacin >256 2 2 0.5 0.5 0.25 0.5 0.5 0.25 1 
Cefepime >256 >256 0.063 0.032 2 2 4 8 16 16 
Cefotaxime >256 >256 0.125 0.063 64 32 32 128 128 128 
Cefoxitin >256 >256 8 4 >256 128 >256 >256 >256 >256 
Ceftazidime >256 >256 0.5 0.25 >256 >256 >256 >256 >256 >256 
Ciprofloxacin 16 ≤0.008 ≤0.008 0.016 0.016 0.008 ≤0.008 0.016 0.008 0.016 
Colistin 1 0.5 0.5 0.125 0.125 0.016 0.125 0.125 ≤0.008 0.125 
Ertapenem 256 128 0.032 0.016 0.25 2 2 64 64 128 
Gentamicin 256 0.5 0.5 0.125 0.125 0.125 0.125 0.063 0.063 0.125 
Imipenem 128 32 0.5 0.5 2 2 2 8 16 16 
Meropenem 128 32 0.063 0.031 1 2 2 8 16 32 
Penicillin G >256 >256 64 32 >256 256 >256 >256 >256 >256 
Tigecycline 0.063 0.063 0.063 0.032 0.032 0.032 0.032 0.063 0.016 0.063 
SXT (1/19)  ≥16/304 0.063/1.2 0.032/0.61 0.5/9.5 0.5/9.5 0.25/4.75 0.25/4.75 0.032/0.61 0.032/0.61 0.063/1.2 
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TABLE 2 Kinetic parameters of NDM-17 and NDM-5 enzymesᵅ 444 
 445 
β-lactam 
NDM-17ᵇ NDM-5b 
kcat/Km (μM
-1 s-1)ratio 
for NDM-17/NDM-5 Km (μM) kcat (s-1)ᵇ kcat/Km (μM-1 s-1) Km (μM) kcat (s-1)ᵇ kcat/Km (μM-1 s-1) 
Ampicillin 586±53 157±11 0.27  590±57 267±8.1 0.45 0.60 
Aztreonam NHᶜ NH NH  NH NH NH NH 
Cefepime 81±5.5 7.5±1.76 0.092  102±7.9 11±2.8 0.11 0.83 
Cefotaxime 11±2.5 11±3.9 1.00  22±5.4 21±5.9 0.95 1.05 
Cefoxitin 23±3.1 5.2±0.04 0.23  45±0.81 6.6±0.47 0.15 1.53 
Ceftazidime 82±8.6 10±1.1 0.12  155±16 21±0.76 0.14 0.86 
Ertapenem 237±25 49±2.6 0.21  571±20 120±7.5 0.21 1.00 
Imipenem 188±0.28 79±2.5 0.42  396±4.3 148±0.64 0.37 1.14 
Meropenem 453±33 127±15 0.28  659±36 222±48 0.34 0.82 
Penicillin G 365±33 115±13 0.32  660±21 93±16 0.14 2.29 
ᵅThe proteins were initially modified with a His tag, which was removed after purification. 446 
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ᵇK
m 
and kcat values are means ± standard deviations from three independent experiments. 447 
ᶜNH denotes no hydrolysis under conditions with substrate concentrations up to 1 mM, and enzyme concentrations up to 700 nM. 448 
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